LIMN
Liminatus Pharma·NASDAQ
--
--(--)
--
--(--)
LIMN fundamentals
Liminatus Pharma (LIMN) released its earnings on Apr 18, 2022: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Apr 18, 2022
EPS
Actual | |
Forecast | |
Surprise | 0.00% |
Revenue
Actual | -- |
Forecast | -- |
Surprise | 0.00% |
Earnings Call
You can ask Aime
What is Liminatus Pharma's latest dividend and current dividend yield?What is the market's earnings forecast for Liminatus Pharma next quarter?What is the revenue and EPS growth rate for Liminatus Pharma year over year?What were the key takeaways from Liminatus Pharma’s earnings call?What is Liminatus Pharma's gross profit margin?What guidance did Liminatus Pharma's management provide for the next earnings period?What does Liminatus Pharma do and what are its main business segments?What were the key takeaways from Liminatus Pharma's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
